Faculty profile
Bowen Li
Back to facultyResearch
Read how they describe their research on their University of Toronto profile.
Latest papers
Nonviral delivery of chemically modified tRNA rescues nonsense mutations in cystic fibrosis.
Science (New York, N.Y.) · 2026 · senior author
Lipid nanoparticle-based multi-scale systemic immune programming for cancer therapy.
Molecular therapy : the journal of the American Society of Gene Therapy · 2026
From serendipity to rational design: Accelerating ionizable lipid discovery with LipidAI.
Acta pharmaceutica Sinica. B · 2026 · first author
Latest funding
- $140,000
Chemical modification of mRNA for enhancing RNA therapeutics
CIHR · 2026 · Supervisor
- $1,239,300
Gene augmentation to treat GRIN Neurodevelopmental Disorder
CIHR · 2026 · Co-investigator
- $1,071,000
Whole organ gene editing for immunomodulation in lung transplantation
CIHR · 2025 · Principal investigator
31 publications.
Nonviral delivery of chemically modified tRNA rescues nonsense mutations in cystic fibrosis.
Chen J, Zhou M, Dong S, Gong F, Tennakoon R, Seto BY, Chen ZR, Zhou ZP, Pan J, Xu Y, Luozhong S, Macarios CM, Tijaro-Bulla S, Gonska T, Hu J, Cui H, Li B
Lipid nanoparticle-based multi-scale systemic immune programming for cancer therapy.
Lin X, Li Y, Shen X, Li B, Xu Y
From serendipity to rational design: Accelerating ionizable lipid discovery with LipidAI.
Li B
Safety risks of intratracheal lipid nanoparticle gene delivery to the lung and potential mitigation strategies.
Nagoya A, Nakajima K, Yune J, Wang A, Guan Z, Xu Y, Dong S, Strilchuk A, Li B, Juvet S, Cypel M, Liu M, Keshavjee S
A multiobjective AI model for LNP engineering enhances tissue-selective mRNA delivery.
Zhou M, Xu Y, Li G, Chen J, Savguira M, Seto B, Gong F, Thomson T, Chen J, Lu RXZ, Dong S, Chen D, Eileen C, Wu S, Zheng G, Li B
Advancing regenerative medicine with RNA nanotechnology for chronic and end organ diseases.
Bakrania A, Nguyen Lefebvre AT, de Vries R, Laflamme MA, Jaeckel E, Hansen He H, Radvanyi L, Hedtrich S, Sahay G, Blakney A, Sefton M, Li B, Zheng G, Bhat M
Amino acid-derived ionizable lipids enable inhaled base editing for therapeutic gene correction in the lung.
Gong F, Xu Y, Chen J, Zhang S, Dong S, Healy L, Seto B, Zhou M, Lu RXZ, Li G, Thomson T, Tang Y, Chen Z, Antonio K, Varley A, Chen DXW, Hodges CA, Wong AP, Hu J, Hubbard BP, Engelhardt JF, Yan Z, Li B
LUMI-lab: A foundation model-driven autonomous platform enabling discovery of ionizable lipid designs for mRNA delivery.
Xu Y, Cui H, Pang K, Li G, Gong F, Dong S, Wang B, Li B
Harnessing artificial intelligence to advance CRISPR-based genome editing technologies.
Thomson T, Li G, Strilchuk A, Cui H, Wang B, Li B
RNA immunotherapy: revolutionizing cancer and autoimmune disease treatments.
Savguira M, Chen DXW, Dong S, Li B
Chemical modification of mRNA for enhancing RNA therapeutics
Principal investigators: Huang, Congcong
Keywords: Chemical Modification; Mrna Therapy; Stimulus Response
Gene augmentation to treat GRIN Neurodevelopmental Disorder
Principal investigators: Ramsey, Amy J
Keywords: Autism; Epilepsy; Gene Therapy; Intellectual Disability; Lipid Nanoparticle; Mouse Behaviour; Movement Disorder; Neurodevelopmental; Nmda Receptor; Rare Disease
Whole organ gene editing for immunomodulation in lung transplantation
Principal investigators: Keshavjee, Shaf; Juvet, Stephen C; Li, Bowen
Keywords: Acute Lung Injury; Chronic Rejection; Crispr; Ex Vivo Lung Perfusion; Gene Therapy; Interleukin (Il)-10; Lipid Nanoparticles; Lung Transplantation; Pre-Clinical Human Model; Whole Organ Gene Editing
Prime Editing for the Therapeutic Correction of the Cystic Fibrosis G542X Mutation
Principal investigators: Thomson, Tyler A
Keywords: Crispr; Cystic Fibrosis; Gene Editing; Gene Therapy; Lipid Nanoparticles; Lung Disease; Nucleic Acids; Prime Editing; Rna; Rna Therapeutics
CRISPR and Artificial Intelligence-designed Retron (CAIR) System Enables Precise Gene Correction of CFTR Nonsense Mutations in Cystic Fibrosis
Principal investigators: Gong, Fanglin
Keywords: Artificial Intelligence / Computational Biology; Cystic Fibrosis; Gene Editing; Lipid Nanoparticle; Protein Engineering
Combinatorial Design of RNA Vaccines for HIV Broadly Neutrazling Antibody Induction
Principal investigators: Li, Bowen
Keywords: Broadly Neutralizing Antibodies; Circular Rna; Hiv; Infectious Diseases; Lipid Nanoparticle; Rna Vaccines
Computationally Engineered Mucosal circRNA Vaccine with ATRA Adjuvant for Broad HIV-1 Protection.
Principal investigators: Selim, Alaa S
Keywords: Atra-Adjuvant; Broadly Neutralizing Antibodies (Bnabs); Cd8+ And Cd4+ T-Cell Activation; Circular Rnas (Circrna) Vaccines; Humanized Mice (Hu-Hsc); Immunoinformatic Analysis; Infectious Diseases (Hiv-1); Lipid Nanoparticle (Lnp); Mucosal Barriers; Women And Lgbtq+ Community
Genetic Engineering of Lungs to Create Universal Blood Type Donor Organs
Principal investigators: Cypel, Marcelo; Wang, Aizhou
Keywords: Abo Incompatible Transplant; Crispr; Ex Vivo Lung Perfusion; Genome Editing; Lung Transplantation; Organ Engineering
Nonviral Delivery of tRNA Therapeutics for Treating Cystic Fibrosis
Principal investigators: Li, Bowen
Keywords: Cystic Fibrosis; Gene Therapy; Lipid Nanoparticles; Nonviral Gene Delivery; Rna Medicine; Trna Biology
Uncovering the role of physiologically relevant biliary signaling in engineering 3D bile duct tubes with human pluripotent stem cell-derived cholangiocytes
Principal investigators: Ogawa, Shinichiro; Zhang, Boyang
Keywords: Biliary Disease; Cholangiopathies; Cystic Fibrosis; Cystic Fibrosis Related Liver Disease; Liver Disease
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Shaf Keshavjee and Marcelo Cypel: 200 shared papers
- Shaf Keshavjee and Mingyao Liu: 109 shared papers
- Mingyao Liu and Marcelo Cypel: 94 shared papers
- Shaf Keshavjee and Stephen Juvet: 39 shared papers
- Marcelo Cypel and Aizhou Wang: 24 shared papers
- Mingyao Liu and Stephen Juvet: 21 shared papers
- Shaf Keshavjee and Aizhou Wang: 20 shared papers
- Marcelo Cypel and Stephen Juvet: 19 shared papers
- Mingyao Liu and Aizhou Wang: 13 shared papers
- Gang Zheng and Mamatha Bhat: 7 shared papers
- Jim Hu and Mingyao Liu: 6 shared papers
- Shaf Keshavjee and BO WANG: 6 shared papers
- Mingyao Liu and BO WANG: 5 shared papers
- Marcelo Cypel and BO WANG: 5 shared papers
- Mamatha Bhat and BO WANG: 5 shared papers
- Jim Hu and Tanja Gonska: 4 shared papers
- Agostino Pierro and Tanja Gonska: 4 shared papers
- Jim Hu and Marcelo Cypel: 3 shared papers
- Gang Zheng and Bowen Li: 3 shared papers
- BO WANG and Bowen Li: 3 shared papers
- Milica Radisic and Andrew Baker: 2 shared papers
- Milica Radisic and Agostino Pierro: 2 shared papers
- Jim Hu and Bowen Li: 2 shared papers
- Shaf Keshavjee and Gang Zheng: 2 shared papers
- Shaf Keshavjee and Mamatha Bhat: 2 shared papers
- Shaf Keshavjee and Tanja Gonska: 2 shared papers
- Bowen Li and Haissi Cui: 2 shared papers
- Milica Radisic and Marcelo Cypel: 1 shared paper
- Milica Radisic and Bowen Li: 1 shared paper
- Jim Hu and Haissi Cui: 1 shared paper
- Shaf Keshavjee and Bowen Li: 1 shared paper
- Mingyao Liu and Andrew Baker: 1 shared paper
- Mingyao Liu and Bowen Li: 1 shared paper
- Andrew Baker and Agostino Pierro: 1 shared paper
- Andrew Baker and Bowen Li: 1 shared paper
- Marcelo Cypel and Bowen Li: 1 shared paper
- Gang Zheng and Michael Sefton: 1 shared paper
- Gang Zheng and Sarah Hedtrich: 1 shared paper
- Gang Zheng and Anna Blakney: 1 shared paper
- Gang Zheng and Haissi Cui: 1 shared paper
- Michael Sefton and Mamatha Bhat: 1 shared paper
- Michael Sefton and Sarah Hedtrich: 1 shared paper
- Michael Sefton and Anna Blakney: 1 shared paper
- Michael Sefton and Bowen Li: 1 shared paper
- Agostino Pierro and Bowen Li: 1 shared paper
- Stephen Juvet and Bowen Li: 1 shared paper
- Mamatha Bhat and Sarah Hedtrich: 1 shared paper
- Mamatha Bhat and Anna Blakney: 1 shared paper
- Mamatha Bhat and Bowen Li: 1 shared paper
- Sarah Hedtrich and Bowen Li: 1 shared paper
- Tanja Gonska and Bowen Li: 1 shared paper
- Anna Blakney and Bowen Li: 1 shared paper
- Bowen Li and Aizhou Wang: 1 shared paper
- Thoracic Surgery
- Institute of Biomaterials and Biomedical Engineering
- Pharmaceutical Sciences
- Chemistry
- Surgery
- Department of Anesthesiology and Pain Medicine
- Michael Smith Laboratories
- Other
Co-authors at University of Toronto, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Gang Zheng
Faculty
3 shared papers, latest 2026
BO WANG
Faculty
3 shared papers, latest 2026
Haissi Cui
Chemistry
2 shared papers, latest 2026
Jim Hu
Faculty
2 shared papers, latest 2026
Aizhou Wang
Thoracic Surgery
1 shared papers, latest 2026
Andrew Baker
Department of Anesthesiology and Pain Medicine
1 shared papers, latest 2024
Marcelo Cypel
Thoracic Surgery
1 shared papers, latest 2026
Michael Sefton
Institute of Biomaterials and Biomedical Engineering
1 shared papers, latest 2026
Agostino Pierro
Surgery
1 shared papers, latest 2024
Stephen Juvet
Toronto General Research Institute
1 shared papers, latest 2026
Mamatha Bhat
Transplant Program
1 shared papers, latest 2026
Sarah Hedtrich
Faculty
1 shared papers, latest 2026
Tanja Gonska
Faculty
1 shared papers, latest 2026
Milica Radisic
Institute of Biomaterials and Biomedical Engineering
1 shared papers, latest 2024
Anna Blakney
Michael Smith Laboratories
1 shared papers, latest 2026
Shaf Keshavjee
Thoracic Surgery
1 shared papers, latest 2026
Mingyao Liu
Department of Surgery
1 shared papers, latest 2026
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.
Profile data last refreshed on September 25, 2026 from the university directory, publication records and CIHR, NSERC and SSHRC funding.